Estrogen replacement therapy

6 marketed 4 in Phase 3

This page covers all Estrogen replacement therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Estrogen receptors (nuclear receptors), Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ).

Targets

Estrogen receptors (nuclear receptors) · Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ)

Marketed (6)

Phase 3 pipeline (4)